Venbio Global Strategic Fund II L.P.

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
17-May-22 5:12 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 16-May-22Sale 95,800$10.45$1,001,100.00(4%)
2.25M to 2.16M
17-May-22 5:12 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 13-May-22Private Sale 35,850$10.45$374,464.00(2%)
2.29M to 2.25M
12-May-22 8:47 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 12-May-22Sale 124,525$10.39$1,294,310.00(5%)
2.41M to 2.29M
12-May-22 8:47 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 11-May-22Sale 17,700$10.38$183,641.00(< 1%)
2.43M to 2.41M
12-May-22 8:47 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 10-May-22Private Sale 18,676$10.38$193,870.00(< 1%)
2.45M to 2.43M
09-May-22 6:58 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 09-May-22Sale 17,600$10.37$182,582.00(< 1%)
2.47M to 2.45M
09-May-22 6:58 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 06-May-22Sale 48,334$10.37$501,233.00(2%)
2.51M to 2.47M
09-May-22 6:58 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 05-May-22Private Sale 20,743$10.37$215,105.00(< 1%)
2.54M to 2.51M
04-May-22 7:30 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 04-May-22Sale 37,500$10.37$388,924.00(1%)
2.57M to 2.54M
04-May-22 7:30 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 03-May-22Sale 79,475$10.37$824,434.00(3%)
2.65M to 2.57M
04-May-22 7:30 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 02-May-22Private Sale 153,700$10.38$1,595,970.00(5%)
2.81M to 2.65M
29-Apr-22 5:50 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 29-Apr-22Sale 69,230$10.38$718,663.00(2%)
2.88M to 2.81M
29-Apr-22 5:50 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 28-Apr-22Sale 73,400$10.38$761,936.00(2%)
2.95M to 2.88M
29-Apr-22 5:50 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 27-Apr-22Private Sale 47,396$10.38$491,980.00(2%)
3.0M to 2.95M
26-Apr-22 6:40 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 26-Apr-22Sale 64,683$10.38$671,558.00(2%)
3.06M to 3.0M
26-Apr-22 6:40 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 25-Apr-22Sale 27,668$10.39$287,404.00(< 1%)
3.09M to 3.06M
26-Apr-22 6:40 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 22-Apr-22Private Sale 37,430$10.39$388,834.00(1%)
3.13M to 3.09M
21-Apr-22 8:54 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 21-Apr-22Sale 62,200$10.38$645,866.00(2%)
3.19M to 3.13M
21-Apr-22 8:54 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 20-Apr-22Sale 85,611$10.39$889,387.00(3%)
3.27M to 3.19M
21-Apr-22 8:54 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 19-Apr-22Private Sale 399,923$10.42$4,165,240.00(11%)
3.67M to 3.27M
29-Apr-21 6:44 PM
View: 
Ipi Legacy Liquidation Co (IMPLQ) 27-Apr-21Conversion 2,309,790----100%
0 to 2.31M
29-Apr-21 6:44 PM
View: 
Ipi Legacy Liquidation Co (IMPLQ) 27-Apr-21Market Purchase 450,000$15.00$6,750,000.0019%
2.31M to 2.76M
12-Aug-20 9:00 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 11-Aug-20Conversion 3,473,370----100%
0 to 3.47M
12-Aug-20 9:00 PM
View: 
Checkmate Pharmaceuticals, ... (CMPI) 11-Aug-20Purchase 200,000$15.00$3,000,000.006%
3.47M to 3.67M
06-Jul-20 7:00 PM
View: 
Akero Therapeutics, Inc. (AKRO) 06-Jul-20Sale 4,603$33.83$155,721.00(< 1%)
3.04M to 3.03M
06-Jul-20 7:00 PM
View: 
Akero Therapeutics, Inc. (AKRO) 02-Jul-20Sale 3,800$33.63$127,805.00(< 1%)
3.04M to 3.04M
06-Jul-20 7:00 PM
View: 
Akero Therapeutics, Inc. (AKRO) 01-Jul-20Sale 108,064$34.45$3,723,010.00(3%)
3.15M to 3.04M
06-Mar-20 5:23 PM
View: 
Akero Therapeutics, Inc. (AKRO) 06-Mar-20Sale 1,800$23.79$42,830.80(< 1%)
3.15M to 3.15M
06-Mar-20 5:23 PM
View: 
Akero Therapeutics, Inc. (AKRO) 05-Mar-20Sale 8,500$23.53$200,011.00(< 1%)
3.16M to 3.15M
06-Mar-20 5:23 PM
View: 
Akero Therapeutics, Inc. (AKRO) 04-Mar-20Sale 35,650$23.81$848,766.00(1%)
3.2M to 3.16M
03-Mar-20 5:52 PM
View: 
Akero Therapeutics, Inc. (AKRO) 03-Mar-20Sale 6,401$23.00$147,199.00(< 1%)
3.2M to 3.2M
03-Mar-20 5:52 PM
View: 
Akero Therapeutics, Inc. (AKRO) 02-Mar-20Sale 10,297$23.06$237,459.00(< 1%)
3.21M to 3.2M
03-Mar-20 5:52 PM
View: 
Akero Therapeutics, Inc. (AKRO) 28-Feb-20Sale 5,100$21.30$108,652.00(< 1%)
3.22M to 3.21M
27-Feb-20 7:51 PM
View: 
Akero Therapeutics, Inc. (AKRO) 27-Feb-20Sale 1,781$22.54$40,143.70(< 1%)
3.23M to 3.23M
27-Feb-20 7:51 PM
View: 
Akero Therapeutics, Inc. (AKRO) 26-Feb-20Sale 2,523$22.44$56,615.40(< 1%)
3.23M to 3.23M
27-Feb-20 7:51 PM
View: 
Akero Therapeutics, Inc. (AKRO) 25-Feb-20Sale 1,600$23.67$37,876.00(< 1%)
3.23M to 3.23M
12-Feb-20 5:56 PM
View: 
Akero Therapeutics, Inc. (AKRO) 12-Feb-20Sale 6$27.14$162.84(< 1%)
3.23M to 3.23M
12-Feb-20 5:56 PM
View: 
Akero Therapeutics, Inc. (AKRO) 11-Feb-20Sale 2,184$27.05$59,068.00(< 1%)
3.24M to 3.23M
12-Feb-20 5:56 PM
View: 
Akero Therapeutics, Inc. (AKRO) 10-Feb-20Sale 7,836$27.08$212,168.00(< 1%)
3.23M to 3.23M
10-Feb-20 5:47 PM
View: 
Akero Therapeutics, Inc. (AKRO) 06-Feb-20Sale 6,102$27.03$164,955.00(< 1%)
3.24M to 3.23M
06-Feb-20 4:06 PM
View: 
Akero Therapeutics, Inc. (AKRO) 05-Feb-20Sale 28,608$25.99$743,548.00(< 1%)
3.27M to 3.24M
06-Feb-20 4:06 PM
View: 
Akero Therapeutics, Inc. (AKRO) 04-Feb-20Sale 53,731$25.65$1,378,180.00(2%)
3.32M to 3.27M
14-Jan-20 8:58 AM
View: 
Akero Therapeutics, Inc. (AKRO) 13-Jan-20Sale 494,000$20.23$9,993,620.00(13%)
3.82M to 3.32M
10-Jan-20 4:06 PM
View: 
Akero Therapeutics, Inc. (AKRO) 08-Jan-20Sale 15,677$19.86$311,355.00(< 1%)
3.83M to 3.82M
08-Jan-20 4:10 PM
View: 
Akero Therapeutics, Inc. (AKRO) 07-Jan-20Sale 31,000$20.17$625,149.00(< 1%)
3.86M to 3.83M
08-Jan-20 4:10 PM
View: 
Akero Therapeutics, Inc. (AKRO) 06-Jan-20Sale 42,221$19.64$829,381.00(1%)
3.91M to 3.86M
06-Jan-20 4:07 PM
View: 
Akero Therapeutics, Inc. (AKRO) 03-Jan-20Sale 12,498$19.30$241,214.00(< 1%)
3.92M to 3.91M
06-Jan-20 4:07 PM
View: 
Akero Therapeutics, Inc. (AKRO) 02-Jan-20Sale 23,000$19.94$458,507.00(< 1%)
3.94M to 3.92M
03-Jan-20 4:13 PM
View: 
Akero Therapeutics, Inc. (AKRO) 31-Dec-19Sale 14,324$23.96$343,259.00(< 1%)
3.95M to 3.94M
25-Jun-19 9:20 AM
View: 
Akero Therapeutics, Inc. (AKRO) 24-Jun-19Conversion
Duplicate
3,704,860----100%
0 to 3.7M